Lynn Miesel

Pharmacology Discovery Services Taiwan, Ltd.

$3,721,895

Attributed

$3,721,895

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2021–24

$2M$1.5M$1M$500K$0

'21

'22

'23

'24

Funding mix

By agency

NIH$3,721,895 · 1

By mechanism

N01$3,721,895 · 1

Top collaborators

No co-investigators on record.

Most similar at Pharmacology Discovery Services Taiwan, Ltd.

Same institution · by research overlap

Anthony Gallacher$2,462,993
Lyne Miesel$950,904
Lynn Misel$434,483

Others in their field

Other Emerging Leaders on “Infectious Disease Model”

Ted Ross · University Of Georgia$71,962,304
Prasant Mohapatra · University Of California At Davis$54,605,575
Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$18,698,011
David Beasley · University Of Texas Med Br Galveston$16,507,955
Greg Westergaard · Alpha Genesis Inc$15,750,123

Research focus

Infectious Disease ModelContractsMouse ModelAnimal ModelStandardizationEfficacy TestingLicensureTherapeutic EvaluationAntimicrobial ResistanceAnimal Model DevelopmentGram-Negative BacteriaInfectionLungBacteremiaThigh StructureBacterial ModelPeritonitisTherapeutic DevelopmentBacterial ResistanceEvaluationBacterial Drug ResistanceBacterial InfectionsCombating Antibiotic Resistant BacteriaBacteriophages